Viewing Study NCT03832335


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-01-02 @ 6:38 AM
Study NCT ID: NCT03832335
Status: UNKNOWN
Last Update Posted: 2019-02-06
First Post: 2019-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A New Measurement of Anseikonia Tolerance
Sponsor: Glostrup University Hospital, Copenhagen
Organization:

Study Overview

Official Title: Can we Measure Aniseikonia Tolerance in a Normal Population
Status: UNKNOWN
Status Verified Date: 2019-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Population 1:

Measure the effect of size glasses from1-9% on stereopsis

Population 2:

Measure the effect of size glasses from 1-9% on stereopsis in two settings:

* before and after cataract surgery
* after dilation of the eye
Detailed Description: Population 1:

21 eye healthy phakic individuals. Measurements: baseline stereopsis and stereopsis after size glass (1-9%) is added in front of the right eye and in front og the left eye. This measurement provides details on how much size difference a person can endure without impairing stereopsis.

Population 2:

11 phakic eye healthy individuals awaiting cataract operation on both eyes. Measurements are the same as population 1 but this study group is also measured after dilating the eyes. This is to see if accommodation affects the measurement. A postoperative measurement six weeks after cataract operation is also performed to examine if cataract operation affects the measurement.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: